Page last updated: 2024-08-17

levodopa and mesulergine

levodopa has been researched along with mesulergine in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	14 (93.33)	18.7374
1990's	1 (6.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goldstein, M; Gopinathan, G; Lieberman, AN; Pasternack, P	1
Chiodini, PG; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Verde, GG	1
Rinne, UK	2
Dupont, E; Jakobsen, J; Mikkelsen, B	1
Montastruc, JL; Rascol, A; Rascol, O; Senard, JM	1
Gopinathan, G; Lieberman, AN; Neophytides, A	1
Baas, H; Fischer, PA; Japp, G; Schneider, E	2
Burton, K; Calne, DB	1
Jellinger, K	1
Biesemeyer, H; Ludin, HP; Ringwald, E	1
Beckman, J; Burton, K; Calne, DB; Martin, WR	1
Fischer, PA; Hubener, K; Schneider, E	2

Reviews

1 review(s) available for levodopa and mesulergine

Article	Year
Medical treatment of pituitary adenomas: effects on tumor growth. Journal of endocrinological investigation, 1985, Volume: 8, Issue:3 Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Dihydroergotoxine; Dopamine; Drug Administration Schedule; Ergolines; Growth Hormone; Levodopa; Lisuride; Metergoline; Methysergide; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed	1985

Trials

4 trial(s) available for levodopa and mesulergine

Article	Year
Mesulergine: a dopamine agonist with novel properties in Parkinson's disease. Advances in neurology, 1990, Volume: 53 Topics: Aged; Dopamine Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1990
Mesulergine in early Parkinson's disease: a double blind controlled trial. Journal of neurology, neurosurgery, and psychiatry, 1986, Volume: 49, Issue:4 Topics: Aged; Antiparkinson Agents; Benserazide; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation	1986
Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism. Journal of neural transmission, 1985, Volume: 64, Issue:1 Topics: Adult; Aged; Blood Pressure; Bromocriptine; Drug Administration Schedule; Ergolines; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	1985
Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085. Journal of neurology, 1982, Volume: 227, Issue:2 Topics: Aged; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine	1982

Other Studies

10 other study(ies) available for levodopa and mesulergine

Article	Year
Dopamine agonists as primary treatment in Parkinson's disease. Advances in neurology, 1987, Volume: 45 Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine	1987
Mesulergine (CU 32-085) in the treatment of Parkinson's disease. Clinical neuropharmacology, 1986, Volume: 9, Issue:2 Topics: Adult; Aged; Antiparkinson Agents; Drug Administration Schedule; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors	1986
Efficacy of pergolide and mesulergine. European neurology, 1986, Volume: 25, Issue:2 Topics: Aged; Antiparkinson Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide	1986
Three-year observation of mesulergine (CU 32-085) in advanced and newly treated parkinsonism. Journal of neurology, 1985, Volume: 232, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1985
Dopamine agonists and Parkinson's disease. Clinical neurology and neurosurgery, 1984, Volume: 86, Issue:3 Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine	1984
Therapeutic experience with the new dopamine agonist CU 32-085 in advanced Parkinson's disease. Journal of neurology, 1983, Volume: 230, Issue:1 Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease	1983
Dopamine agonists in Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:1 Suppl Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2	1984
Dopamine agonists in the treatment of Parkinson's disease. Advances in neurology, 1983, Volume: 37 Topics: Blood Pressure; Bromocriptine; Disability Evaluation; Domperidone; Dopamine; Ergolines; Follow-Up Studies; Humans; Levodopa; Parkinson Disease; Pleural Effusion; Receptors, Neurotransmitter; Time Factors	1983
Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085. Neurology, 1983, Volume: 33, Issue:4 Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychomotor Performance; Receptors, Dopamine	1983
Therapeutic results with a new ergoline derivate (8-alpha-amino-ergoline, CU 32-085) in parkinsonian patients. Advances in neurology, 1984, Volume: 40 Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1984